MARKET

KLTO

KLTO

Klotho Neurosciences, Inc.
NASDAQ
0.2402
+0.0195
+8.84%
After Hours: 0.2345 -0.0057 -2.37% 19:54 02/06 EST
OPEN
0.2309
PREV CLOSE
0.2207
HIGH
0.2427
LOW
0.2229
VOLUME
605.21K
TURNOVER
--
52 WEEK HIGH
3.910
52 WEEK LOW
0.1135
MARKET CAP
17.66M
P/E (TTM)
-0.7359
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at KLTO last week (0126-0130)?
Weekly Report · 5d ago
Weekly Report: what happened at KLTO last week (0119-0123)?
Weekly Report · 01/26 10:20
Weekly Report: what happened at KLTO last week (0112-0116)?
Weekly Report · 01/19 10:26
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga · 01/15 12:05
Klotho Neuroscience Inc. Announces Date for Upcoming Special Stockholders Meeting
Reuters · 01/12 20:49
Weekly Report: what happened at KLTO last week (0105-0109)?
Weekly Report · 01/12 10:25
Klotho Neurosciences to Present at Biotech Showcase
Reuters · 01/08 13:02
Coinbase CEO Brian Armstrong Says His Biotech Company Is Working On 'Extending' Human Lifespan: Here Is How They Plan To Do It
Benzinga · 01/06 07:24
More
About KLTO
Klotho Neurosciences, Inc. develops essential medicines for the treatment of chronic diseases such as cancer, cardiovascular, and neurodegenerative disorders. The Company's licensed platforms, namely, a generic drug portfolio and a biosimilar biologics platform uses biologic therapies to treat cancer, and a proprietary, patented gene therapy platform which uses a gene therapy approach to introduce a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases. Its primary focus is the advancement of a sustainable portfolio of cell and gene therapy product candidates for age-associated neurologic diseases, both rare orphan diseases and diseases in larger patient populations. The Company's two lead gene therapy product candidates are KLTO-101 (AAV9-CMV-sKL) for the treatment or prevention of Alzheimer’s disease, and KLTO-202 (AAVmyo-Des-sKL) gene therapy product for the treatment and prevention of Lou Gehrig’s disease (amyotrophic lateral sclerosis).

Webull offers Klotho Neurosciences Inc stock information, including NASDAQ: KLTO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, KLTO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading KLTO stock methods without spending real money on the virtual paper trading platform.